The groundbreaking approach of this peptide represents a major advance in the handling of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide964142.bcbloggers.com/40761289/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment